84B-29536-69058
4 vaccinations
8 coded responses
40 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 100 / NY
- Registered
- 2021-05-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-18
Dose 1 — Pfizer-BioNTech
-
2021-05-22
Registered in v-safe
-
2021-05-22
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-23
- 2021-05-24
- 2021-05-25
-
2021-06-01
Survey response — day 14, dose 1MedDRA: Chills, Headache, Lacrimation increased, Self-medication — Feeling: GoodFree text: 5/26Mild headache: took 1 AdvilEvening: slight chills for a few seconds 5/27: headache got worse: took 3 Advils; teary right eye for a few daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-08
Dose 2 — Pfizer-BioNTech
- 2021-06-22
- 2021-06-29
- 2021-07-06
- 2021-07-13
- 2021-07-20
- 2021-09-07
- 2021-12-07
-
2021-12-10
Dose 3 — Pfizer-BioNTech
- 2021-12-11
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Injection site discolouration, Injection site pruritus — Feeling: Good · Site: Redness, ItchingFree text: Injection site: not really redness but pinkish, slight itchy morning.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-03-12
-
2022-05-17
Dose 4 — Pfizer-BioNTech
- 2022-05-17
-
2022-05-18
Survey response — days 1–6 daily, dose 4MedDRA: Lethargy — Feeling: Good · Site: PainFree text: Slightly lethargic.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Survey response — days 1–6 daily, dose 4MedDRA: Headache, Injection site erythema — Feeling: Fair · Site: Redness · Headache, Fatigue or tirednessFree text: Experienced redness yesterday at injection site and headache late afternoon through today, but not certain whether it is vaccine related. Thanks.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema — Feeling: GoodFree text: Redness around vaccination site fading, barely noticeable.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema — Feeling: GoodFree text: Injection site: slightly pink, fadingMedDRA releases: 2024-11 · check-in free text available
- 2022-05-22
- 2022-05-23
- 2022-05-24
-
2022-05-31
Survey response — day 14, dose 4MedDRA: Chills, Cough, Rhinorrhoea — Feeling: PoorFree text: As of evening 5/27: Chills through 5/29. Very runny nose 5/28-29. Dry cough: 5/29-present (5/31). Not sure whether it is a regular cold.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-08-16
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-18 | Pfizer-BioNTech | |
| 2 | 2021-06-08 | Pfizer-BioNTech | No |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-05-17 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): None
Release 8 — day 14, dose 1
Symptoms: 5/26Mild headache: took 1 AdvilEvening: slight chills for a few seconds 5/27: headache got worse: took 3 Advils; teary right eye for a few days
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Injection site: not really redness but pinkish, slight itchy morning.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Slightly lethargic.
Systemic reaction (other): Experienced redness yesterday at injection site and headache late afternoon through today, but not certain whether it is vaccine related. Thanks.
Systemic reaction (other): Redness around vaccination site fading, barely noticeable.
Systemic reaction (other): Injection site: slightly pink, fading
Release 11 — day 14, dose 4
Symptoms: As of evening 5/27: Chills through 5/29. Very runny nose 5/28-29. Dry cough: 5/29-present (5/31). Not sure whether it is a regular cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Lethargy | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release